A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 43,525 shares of CDMO stock, worth $535,357. This represents 0.09% of its overall portfolio holdings.

Number of Shares
43,525
Previous 67,542 35.56%
Holding current value
$535,357
Previous $482 Million 2.71%
% of portfolio
0.09%
Previous 0.1%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$6.7 - $12.45 $160,913 - $299,011
-24,017 Reduced 35.56%
43,525 $495 Million
Q2 2024

Aug 14, 2024

BUY
$6.34 - $9.28 $358,641 - $524,951
56,568 Added 515.47%
67,542 $482 Million
Q1 2024

May 15, 2024

BUY
$5.86 - $8.79 $30,407 - $45,611
5,189 Added 89.7%
10,974 $73.5 Million
Q4 2023

Feb 14, 2024

BUY
$4.64 - $9.56 $26,842 - $55,304
5,785 New
5,785 $37.6 Million

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $765M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Point72 Asia (Singapore) Pte. Ltd. Portfolio

Follow Point72 Asia (Singapore) Pte. Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asia (Singapore) Pte. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asia (Singapore) Pte. Ltd. with notifications on news.